| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |